Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Dana 1420A, 450 Brookline Avenue, Boston, MA 02215, USA.
J Mol Med (Berl). 2012 Jan;90(1):15-24. doi: 10.1007/s00109-011-0802-y. Epub 2011 Aug 23.
The human intestine harbors a large number of bacteria that are constantly interacting with the intestinal immune system, eliciting non-pathological basal level immune responses. Increasing evidence points to dysbiosis of microbiota in the intestine as an underlying factor in inflammatory bowel disease susceptibility. Loss-of-function mutations in NOD2 are among the stronger genetic factors linked to ileal Crohn's disease. Indeed, Nod2 is a key regulator of microbiota in the intestine, as microflora in the terminal ileum is dysregulated in Nod2-deficient mice. Nod2 is highly expressed in Paneth cells, which are responsible for the regulation of ileal microflora by anti-microbial compounds, and Nod2-deficient ileal intestinal epithelia are unable to kill bacteria efficiently. It is therefore likely that NOD2 mutations in Crohn's disease may increase disease susceptibility by altering interactions between ileal microbiota and mucosal immunity.
人类肠道中栖息着大量的细菌,这些细菌不断与肠道免疫系统相互作用,引发非病理性的基础免疫反应。越来越多的证据表明,肠道微生物群落失调是炎症性肠病易感性的一个潜在因素。NOD2 基因的功能丧失突变是与回肠克罗恩病相关的较强遗传因素之一。事实上,Nod2 是肠道微生物群落的关键调节因子,因为末端回肠中的微生物群落失调在 Nod2 缺陷型小鼠中发生。Nod2 在潘氏细胞中高度表达,潘氏细胞负责通过抗菌化合物调节回肠微生物群落,而 Nod2 缺陷型回肠肠上皮细胞无法有效地杀死细菌。因此,在克罗恩病中 NOD2 突变可能通过改变回肠微生物群落与黏膜免疫之间的相互作用而增加疾病易感性。